Close Menu
Technology Mag

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Microsoft trumps Google with $30 billion investment in the UK

    September 16, 2025

    How AI Is Upending Politics, Tech, the Media, and More

    September 16, 2025

    Consumer Reports asks Microsoft to keep supporting Windows 10

    September 16, 2025
    Facebook X (Twitter) Instagram
    Subscribe
    Technology Mag
    Facebook X (Twitter) Instagram YouTube
    • Home
    • News
    • Business
    • Games
    • Gear
    • Reviews
    • Science
    • Security
    • Trending
    • Press Release
    Technology Mag
    Home » Ozempic Could Also Help You Drink Less Alcohol
    Science

    Ozempic Could Also Help You Drink Less Alcohol

    News RoomBy News RoomDecember 4, 20233 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Another reason for the trial’s failure could be that exenatide is much less potent than its newer cousin semaglutide, better known as Ozempic. Now that Ozempic is everywhere, anecdotal evidence is mounting that these drugs reduce cravings not just for food, but for online shopping, smoking, nail-biting, and alcohol.

    Now, the first empirical evidence to support the idea that drugs like Ozempic could be an effective treatment for AUD is beginning to appear. This week, a new paper published in the Journal of Clinical Psychiatry strengthened the case. The paper relayed a series of case studies: six patients who had been prescribed semaglutide for weight loss, but who also qualified for having AUD. All six of the participants displayed significantly reduced symptoms of AUD—even those who had achieved minimal weight loss.

    This small study is only the beginning. The authors are also running a clinical trial in Tulsa, Oklahoma, looking at semaglutide to treat AUD; a sister study is being conducted in Baltimore, Maryland. It’ll be at least a year and a half before those trials have publishable data, so this case series was done in order to set the table for the clinical trial data, say study authors Kyle Simmons, professor of pharmacology and physiology at Oklahoma State University, and Jesse Richards, assistant professor of medicine at the University of Oklahoma. (Richards receives payment from Novo Nordisk and Eli Lilly, who make GLP-1 receptor agonist drugs, to speak at conferences.)

    While scientists aren’t certain how these drugs work to dampen alcohol cravings, it’s suspected to work on the same pathways that produce a shrunken appetite. A thirst for booze is thought to be driven by the rewarding properties that alcohol produces, delivered by a bump of dopamine released in the brain. Over time, that dopamine flurry reinforces a want for alcohol.

    GLP-1 receptors are found dotted around the body, including in the brain structures that control our reward pathways. These receptors control the release of the hormone GLP-1, which has a multitude of roles to play in the body, including how we respond to alcohol.

    What drugs like semaglutide, which mimic the actions of GLP-1, seem to do is lower the amount of the substance required—like food or alcohol—to feel satiated. Richards says some patients report going to an event where they’d normally expect to drink a lot, like a sports game or a fishing trip, “and instead of drinking their normal amount, they would drink one drink, and then kind of get bored and forget about it,” he says.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticleSpace lasers!
    Next Article Verizon’s new Netflix and Max bundle costs $10 / month with ads

    Related Posts

    US Taxpayers Will Pay Billions in New Fossil Fuel Subsidies Thanks to the Big Beautiful Bill

    September 15, 2025

    The New Math of Quantum Cryptography

    September 15, 2025

    ‘People Are So Proud of This’: How River and Lake Water Is Cooling Buildings

    September 15, 2025

    Researchers Create 3D-Printed Artificial Skin That Allows Blood Circulation

    September 15, 2025

    Falcon 9 Milestones Vindicate SpaceX’s ‘Dumb’ Approach to Reuse

    September 14, 2025

    Why Former NFL All-Pros Are Turning to Psychedelics

    September 13, 2025
    Our Picks

    How AI Is Upending Politics, Tech, the Media, and More

    September 16, 2025

    Consumer Reports asks Microsoft to keep supporting Windows 10

    September 16, 2025

    Can Luigi Mangione get too big to jail?

    September 16, 2025

    Hundreds of Google AI Workers Were Fired Amid Fight Over Working Conditions

    September 16, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    News

    Sam Altman says ChatGPT will stop talking about suicide with teens

    By News RoomSeptember 16, 2025

    On Tuesday, OpenAI CEO Sam Altman said that the company was attempting to balance privacy,…

    Charlie Kirk’s death got complicated by gamer brainrot

    September 16, 2025

    Wyze’s new palm-scanning door lock has a second, backup battery

    September 16, 2025

    Here’s What to Know About Poland Shooting Down Russian Drones

    September 16, 2025
    Facebook X (Twitter) Instagram Pinterest
    • Privacy Policy
    • Terms of use
    • Advertise
    • Contact
    © 2025 Technology Mag. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.